Walgreens gets in early on healthy growth in China

Adjust Comment Print

More interesting news about Walgreens Boots Alliance, Inc. The stock has performed -2.85% over the last seven days, 4.95% over the last thirty, and -14.16% over the last three months. IBM Retirement Fund raised its stake in Walgreens Boots Alliance by 88.1% during the second quarter.

The stock decreased 1.31% or $0.94 during the last trading session, reaching $70.63. Andra AP fonden raised its stake in Walgreens Boots Alliance by 35.3% during the second quarter.

Walgreens Boots Alliance Inc (WBA) traded up 0.475% during midday trading on Thursday, hitting $81.405.

Earnings Per Share (EPS) is the earnings made by a company divided by their number of shares.


Walgreens will acquire the minority stake from GuoDa's parent, China National Accord Medicines. Institutions now own 62.20% of the company.

Walgreens Boots Alliance, Inc.'s RSI is 47.39. WBA's profit will be $1.25 billion for 14.01 P/E if the $1.26 EPS becomes a reality. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, October 25th. (NASDAQ:WBA) to report earnings on January, 4. Walgreens Boots Alliance had a net margin of 3.52% and a return on equity of 16.76%. The stock of Walgreens Boots Alliance, Inc. WBA has a net profit margin of 3.40% and is more profitable than the average company in the Drug Stores industry. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator's stock worth $713,000 after purchasing an additional 750 shares during the period. Shares buyback programs are typically an indication that the company's leadership believes its stock is undervalued. Shareholders of record on Monday, November 13th will be paid a dividend of $0.40 per share. At the current valuation, this equates to a dividend yield of 2.28%. The ex-dividend date of this dividend is Friday, November 10th. The MF Rank of Walgreens Boots Alliance, Inc. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and fourteen have issued a buy rating to the company's stock. This will give analytical advantage to a shorter-term trader since it pursues the price more intimately, and consequently produces less "lag" as comparison to the longer-term moving average. Insiders own 13.50% of the company's stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The average investment recommendation for WBA, taken from a group of Wall Street Analysts, is 2.20, or a buy. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. The disclosure for this purchase can be found here.

A number of research analysts recently weighed in on WBA shares. The target price per share by Deutsche Bank suggests upside of 10.43 % from the last price. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator's stock valued at $258,077,000 after buying an additional 2,718,800 shares during the last quarter. (NasdaqGS:WBA) for last month was 1.09178. Walgreens Boots Alliance now has a consensus rating of "Buy" and a consensus target price of $90.62.


Walgreens Boots Alliance declared that its board has authorized a share buyback program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. Jefferies Group reissued a "buy" rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. The rating was maintained by Pivotal Research with "Hold" on Thursday, June 29. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2017/12/06/brokerages-set-walgreens-boots-alliance-inc-wba-target-price-at-86-53.html.

COPYRIGHT VIOLATION NOTICE: This news story was published by Week Herald and is the sole property of of Week Herald.

Analysts await Walgreens Boots Alliance, Inc. The Company is a global pharmacy-led, health and wellbeing enterprise. The 14-day RSI is now sitting at 51.63, the 7-day is at 50.79, and the 3-day is spotted at 48.25 for Walgreens Boots Alliance (WBA). The joint venture operates pharmacies under a local brand.


Comments